An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)
Clinical trial NCT00127101 · TERMINATED
Trial details
- NCT number
- NCT00127101
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2008-10-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.